澳洋健康:澳洋醫藥物流擬向蘇州樂天防護用品增資500萬元
格隆匯2月10日丨澳洋健康(002172.SZ)公佈,公司全資子公司江蘇澳洋醫藥物流有限公司(以下簡稱“澳洋醫藥物流”)與蘇州樂天防護用品有限公司(以下簡稱“樂天”或“目標公司”)及其股東徐英、張文簽訂《增資協議》。澳洋醫藥物流出資人民幣500萬元對樂天進行增資,其中人民幣86萬元計入樂天註冊資本,其餘計入其資本公積。本次增資完成後,公司持有樂天30.07%股權。
樂天具有醫療器械生產許可證,通過LA及ISO9001認證,建有10萬級淨化車間,可生產醫用級口罩及各類防護級別的成人、兒童口罩。目前,樂天日口罩生產量達到60萬隻。樂天產品覆蓋一次性醫用外科口罩、一次性醫用口罩、各類防護級別的成人、兒童口罩。
鑑於當前突發的疫情防控形勢,社會對口罩等防疫物資需求迫切,但供給緊張。樂天擁有生產醫用級口罩及各類防護級別的成人、兒童口罩的生產資質及能力,澳洋醫藥物流決定通過對樂天增資參股的形式,在業務上與樂天形成戰略合作,保證澳洋醫藥物流的口罩採購渠道穩定,滿足下游醫院及零售終端的需求,積極響應黨和政府號召,承擔企業的社會責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.